Peptide Dosing Chart

50 commonly discussed peptides and 8 popular stacks, with a reconstitution calculator. Select a row to see its details.

		Typical dose			Reviews / Q&A	Route
SemaglutideOzempic, Wegovy	Weight & metabolic	0.25 mg rising to 2.4 mg	Weekly	≈ 36–343 mcg/day	Add review	Subcutaneous	FDA-approved
TirzepatideMounjaro, Zepbound	Weight & metabolic	2.5 mg rising to 5–15 mg	Weekly	≈ 0.36–2.1 mg/day	Add review	Subcutaneous	FDA-approved
RetatrutideLY3437943	Weight & metabolic	1–12 mg	Weekly	≈ 0.14–1.7 mg/day	Add review	Subcutaneous	Clinical trials
LiraglutideSaxenda, Victoza	Weight & metabolic	0.6 mg rising to 3 mg	Daily	0.6–3 mg/day	Add review	Subcutaneous	FDA-approved
Cagrilintidepart of CagriSema	Weight & metabolic	0.25 mg rising to 2.4 mg	Weekly	≈ 36–343 mcg/day	Add review	Subcutaneous	Clinical trials
SurvodutideBI 456906	Weight & metabolic	0.6–6 mg	Weekly	≈ 86–857 mcg/day	Add review	Subcutaneous	Clinical trials
MazdutideIBI362	Weight & metabolic	4 mg or 6 mg	Weekly	≈ 0.57–0.86 mg/day	Add review	Subcutaneous	Approved outside US
SetmelanotideImcivree	Weight & metabolic	2 mg rising to 3 mg	Daily	2–3 mg/day	Add review	Subcutaneous	FDA-approved
PramlintideSymlin	Weight & metabolic	15–120 mcg per meal	Daily, with each meal	≈ 45–360 mcg/day	Add review	Subcutaneous	FDA-approved
AOD-9604hGH fragment 177-191 analog	Weight & metabolic	300 mcg	Daily	300 mcg/day	Add review	Subcutaneous	Not approved
HGH Fragment 176-191Frag 176-191	Weight & metabolic	250–500 mcg	Daily	250–500 mcg/day	Add review	Subcutaneous	Not approved
TesofensineNS2330	Weight & metabolic	0.25–0.5 mg	Daily	0.25–0.5 mg/day	Add review	Oral	Clinical trials
5-Amino-1MQNNMT inhibitor	Weight & metabolic	50–150 mg	Daily	50–150 mg/day	Add review	Oral	Not approved
CJC-1295 (no DAC)Mod GRF 1-29	Growth hormone	100 mcg	Daily, 1–3 times	100–300 mcg/day	Add review	Subcutaneous	Not approved
CJC-1295 with DACDAC:GRF	Growth hormone	1–2 mg	Weekly	≈ 143–286 mcg/day	Add review	Subcutaneous	Not approved
Ipamorelin	Growth hormone	100–300 mcg	Daily, 1–3 times	100–900 mcg/day	Add review	Subcutaneous	Not approved
SermorelinGeref	Growth hormone	200–500 mcg	Daily, at bedtime	200–500 mcg/day	Add review	Subcutaneous	Not approved
TesamorelinEgrifta SV, Egrifta WR	Growth hormone	1.4 mg (SV) or 1.28 mg (WR)	Daily	1.28–1.4 mg/day	Add review	Subcutaneous	FDA-approved
GHRP-2pralmorelin	Growth hormone	100–300 mcg	Daily, 1–3 times	100–900 mcg/day	Add review	Subcutaneous	Not approved
GHRP-6	Growth hormone	100–300 mcg	Daily, 1–3 times	100–900 mcg/day	Add review	Subcutaneous	Not approved
Hexarelinexamorelin	Growth hormone	100–200 mcg	Daily, 1–3 times	100–600 mcg/day	Add review	Subcutaneous	Not approved
MK-677ibutamoren	Growth hormone	10–25 mg	Daily	10–25 mg/day	Add review	Oral	Clinical trials
IGF-1 LR3long R3 IGF-1	Growth hormone	20–50 mcg	Daily	20–50 mcg/day	Add review	Subcutaneous or intramuscular	Not approved
BPC-157body protection compound	Healing & recovery	250–500 mcg	Daily	250–500 mcg/day	Add review	Subcutaneous or oral	Not approved
TB-500thymosin beta-4 fragment	Healing & recovery	2–5 mg per week	Twice weekly	≈ 0.29–0.71 mg/day	Add review	Subcutaneous	Not approved
GHK-Cucopper peptide	Healing & recovery	1–2 mg	Daily	1–2 mg/day	Add review	Subcutaneous or topical	Not approved
KPValpha-MSH fragment	Healing & recovery	200–500 mcg	Daily	200–500 mcg/day	Add review	Subcutaneous or oral	Not approved
LL-37cathelicidin	Healing & recovery	50–100 mcg	Daily	50–100 mcg/day	Add review	Subcutaneous	Not approved
ARA-290cibinetide	Healing & recovery	4 mg	Daily	4 mg/day	Add review	Subcutaneous	Clinical trials
VIPvasoactive intestinal peptide, aviptadil	Healing & recovery	50 mcg per spray	Daily, up to 4 times	up to 200 mcg/day	Add review	Intranasal	Clinical trials
Semax	Cognitive & sleep	200–900 mcg per day	Daily, 2–3 times	200–900 mcg/day	Add review	Intranasal	Approved outside US
Selank	Cognitive & sleep	300–900 mcg per day	Daily, 2–3 times	300–900 mcg/day	Add review	Intranasal	Approved outside US
DihexaPNB-0408	Cognitive & sleep	8–20 mg	Daily	8–20 mg/day	Add review	Oral	Not approved
DSIPdelta sleep-inducing peptide	Cognitive & sleep	100–250 mcg	Daily, at bedtime	100–250 mcg/day	Add review	Subcutaneous	Not approved
Cerebrolysin	Cognitive & sleep	5–30 mL	Daily, in short courses	5–30 mL/day	Add review	Intramuscular or intravenous	Approved outside US
Cortexin	Cognitive & sleep	10 mg	Daily, in short courses	10 mg/day	Add review	Intramuscular	Approved outside US
Epitalonepithalon	Longevity & immune	5–10 mg	Daily, in short courses	5–10 mg/day during a course	Add review	Subcutaneous	Not approved
Thymosin alpha-1thymalfasin, Zadaxin	Longevity & immune	1.6 mg	Twice weekly	≈ 0.46 mg/day	Add review	Subcutaneous	Approved outside US
MOTS-c	Longevity & immune	5–10 mg	2–3 times weekly	≈ 1.4–4.3 mg/day	Add review	Subcutaneous	Not approved
SS-31elamipretide, Forzinity	Longevity & immune	40 mg	Daily	40 mg/day	Add review	Subcutaneous	FDA-approved
NAD+nicotinamide adenine dinucleotide	Longevity & immune	50–200 mg	Daily to 2–3 times weekly	up to 200 mg/day	Add review	Subcutaneous	Not approved
Thymalin	Longevity & immune	5–20 mg	Daily, in short courses	5–20 mg/day during a course	Add review	Intramuscular	Approved outside US
PT-141bremelanotide, Vyleesi	Sexual, hormonal & skin	1.75 mg	As needed	Not a daily drug	Add review	Subcutaneous	FDA-approved
Melanotan IIMT-2	Sexual, hormonal & skin	250–500 mcg	Daily, then 1–2 times weekly	250–500 mcg/day	Add review	Subcutaneous	Not approved
Melanotan Iafamelanotide, Scenesse	Sexual, hormonal & skin	16 mg implant	Every 2 months	≈ 0.27 mg/day	Add review	Subcutaneous implant	FDA-approved
Kisspeptin-10	Sexual, hormonal & skin	100–200 mcg	As needed	100–200 mcg/day	Add review	Subcutaneous	Clinical trials
OxytocinPitocin (injection)	Sexual, hormonal & skin	10–40 IU per dose	Daily, 1–2 times	Measured in IU, not mcg	Add review	Intranasal	Not approved
GonadorelinGnRH	Sexual, hormonal & skin	100 mcg	2–3 times weekly	≈ 29–43 mcg/day	Add review	Subcutaneous	Not approved
TeriparatideForteo	Bone	20 mcg	Daily	20 mcg/day	Add review	Subcutaneous	FDA-approved
AbaloparatideTymlos	Bone	80 mcg	Daily	80 mcg/day	Add review	Subcutaneous	FDA-approved
Ad Medtruva Research-grade peptides verified by HPLC and mass spectrometry, with a lot-matched Certificate of Analysis on every vial. For laboratory research only. Visit Medtruva Paid placement. Peppapete has a business relationship with Medtruva.
Stacks & blends: combinations of the peptides above
Wolverine stackBPC-157 + TB-500	Stacks & blends	BPC-157 10 mgTB-500 10 mgper pre-mixed vial	BPC-157 daily, TB-500 twice weekly	BPC-157 250–500 mcg; TB-500 2–5 mgreported online, not an established dose	Blend calculator	Varies	No trial of combination
GLOWGHK-Cu + BPC-157 + TB-500	Stacks & blends	GHK-Cu 50 mgBPC-157 10 mgTB-500 10 mgper pre-mixed vial	Daily	10 units: GHK-Cu 1.67 mg, BPC-157 0.33 mg, TB-500 0.33 mgreported online, not an established dose	Blend calculator	Varies	No trial of combination
KLOWGHK-Cu + BPC-157 + TB-500 + KPV	Stacks & blends	GHK-Cu 50 mgBPC-157 10 mgTB-500 10 mgKPV 10 mgper pre-mixed vial	Daily	Sources differ tenfold: 0.2–0.5 mg or 2–6 mg of blendreported online, not an established dose	Blend calculator	Varies	No trial of combination
CJC-1295 + Ipamorelinthe growth hormone blend	Stacks & blends	CJC-1295 (no DAC) 5 mgIpamorelin 5 mgper pre-mixed vial	Daily, before bed	100–300 mcg of eachreported online, not an established dose	Blend calculator	Subcutaneous	No trial of combination
Tesamorelin + Ipamorelin	Stacks & blends	Separate vialsTesamorelin + Ipamorelin	5 days a week, before bed	Tesamorelin 0.6–1.5 mg + ipamorelin 0.2–0.75 mgreported online, not an established dose	View stack	Subcutaneous	No trial of combination
CagriSemacagrilintide + semaglutide	Stacks & blends	One manufactured injection, in trials onlyCagrilintide + Semaglutide	Weekly	2.4 mg + 2.4 mg (trial target dose)from the trial	View stack	Subcutaneous	Clinical trials
MOTS-c + SS-31the mitochondrial stack	Stacks & blends	Separate vialsMOTS-c + SS-31	Daily, or 3 times a week	Sources differ: MOTS-c 1–15 mg, SS-31 1–10 mgreported online, not an established dose	View stack	Subcutaneous	No trial of combination
Semax + Selankthe nootropic pair	Stacks & blends	Separate vialsSemax + Selank	2–3 times a day, nasal	Semax 400–600 mcg a day; Selank 400–750 mcg a dayreported online, not an established dose	View stack	Intranasal	No trial of combination

Showing 50 of 50 peptides and 8 of 8 stacks

Semaglutide

Also known as: Ozempic, Wegovy

FDA-approved

Category: Weight & metabolic
Typical dose: 0.25 mg rising to 2.4 mg
How often: Weekly
Schedule: Once weekly. Start at 0.25 mg and step up every 4 weeks: 0.5, 1, 1.7, then 2.4 mg.
Daily equivalent: ≈ 36–343 mcg/day
Reviews / Q&A: Add review
Route: Subcutaneous
Duration: Ongoing

Wegovy schedule shown. A 7.2 mg weekly dose (Wegovy HD) was approved in March 2026 for adults who have tolerated 2.4 mg for at least 4 weeks. Ozempic for diabetes is maintained at 0.5–2 mg weekly. Brand products are prefilled pens; the calculator applies to vials only. Boxed warning for thyroid C-cell tumors.

Open the full Semaglutide page

Reconstitution calculator

Peptide in vial (mg)

Water added (mL)

Dose per injection

Syringe (U-100 insulin)

Draw to 10 units

0.1 mL on a 100-unit syringe

2.5 mg/mLconcentration

25 mcgper unit mark

20doses per vial

Stacks and blends

What is in each named combination, how the pre-mixed vials are made up, and what evidence exists for it.

“Daily equivalent” spreads weekly or intermittent doses evenly across seven days so entries can be compared; it is not a suggestion to dose daily. Vial sizes pre-filled in the calculator are common examples. Always enter the amount printed on your own vial. Doses for the FDA-approved entries were checked against US prescribing information in October 2026. Labels change, so confirm against the current one.

Reference only, not medical advice. Doses marked FDA-approved come from the US prescribing label. Doses marked Not approved are ranges reported from small studies or community use and have not been established as safe or effective in humans. Check anything here with a licensed clinician before acting on it. Read the full disclaimer.

Peptide Dosing Chart

Get the printable dosing chart

Stacks and blends

Popular comparisons